Intravenous infusions of nitroglycerin decreased systemic systolic, pulmonary systolic and wedge pressures in f3-blocked patients anaesthetised for coronary artery surgery with high dose of fentanyl without changing heart rate, diastolic pressure, or cardiac index, thus leading to an improvement in endocardial viability ratio. The use of a nitroglycerin bolus to abort an acute myocardial ischaemic episode is described.
In patients undergoing surgery, conscious reactions to surgical stimuli are prevented by adequate general anaesthesia, which may, however, leave autonomic reflexes intact. Increased sympathetic tone and catecholamine release are of little consequence in the patient with a normal cardiovascular system, but when cardiovascular disease is present, these stress responses may load the heart to an unacceptable degree. This effect is of special importance when there is atheromatous occlusion of the coronary circulation, reducing its ability to supply extra oxygen in the face of increased myocardial work.
Thus the possible result of surgical hypertension in such a patient is myocardial ischaemia, either regional, corresponding to the supply area of a coronary artery, or diffuse, usually in the sub-endocardial layer , blood flow to which may be further decreased by a concomitant rise in ventricular end diastolic pressure.
Therefore during surgery on patients with coronary vascular disease, the anaesthetic technique should be directed towards mInImISIng this stress reaction, either by blocking afferent pain pathways, or by deepening general anaesthesia, or by exhibiting drugs which block the effects of increased sympathetic tone. In our unit, high dose fentanyl anaesthesia is used for patients scheduled for coronary vein grafting, and we have investigated the additional effects produced by a continuous infusion of nitroglycerin in the pre-cardiopulmonary bypass period.
MATERIALS AND METHODS
In all cases the anaesthetic technique was as follows.
Patients received flunitrazepam 2 mg orally one hour before operation. Before induction of anaesthesia, peripheral venous, radial artery, and pulmonary artery catheters were inserted and the following recordings were made (Stage I).
Heart Electrocardiography from all limb leads and the V5 position. Once these measurements had been completed, oxygen was administered, and anaesthesia induced with flunitrazepam 1.5 mg intravenously, together with fentanyl 2.5-5 /A/kg and pancuronium 0.1 mg/kg. After three minutes the trachea was intubated, and ventilation with nitrous oxide:oxygen 1: 1 was set to maintain a P aC02 between 36 and 40 mmHg at a respiratory rate of 12/minute. Just before the skin incision, all measurements were again repeated (Stage 11) following which an additional flunitrazepam 0.5 mg and fentanyl 7.5 /A/kg were given. Thereafter additional increments of 50 /Ag fentanyl were given every three minutes.
The last set of measurements (Stage Ill) was made immediately after the sternotomy. Between Stages I and Ill, patients received 200-300 ml 5070 dextrose and 500 ml of dextran intravenously.
Altogether 28 patients were investigated, each one being randomly assigned to either a control group (14 patients) or a nitroglycerin group (14 patients) , in which intravenous nitroglycerin * was administered after the induction, from a perfusion pump through high density poly ethylene tubing.' The initial infusion rate was at 0.5 /Ag/kg/min and the State II measurements were made at least 15 minutes after the start of the infusion. The rate was then increased to 3 /Ag/kg/min, and the Systolic and diastolic times were measured from the radial artery pressure curve.
Means and standard deviations were calculated and changes in the two groups at Stages 11 and III were compared using the student t-test. Table 1 shows the sex, mean age, weight, surface area and number of grafts done in each group. All patients were on long term {3-blockade therapy. RESULTS These are shown in Figures 1-4 . When the changes from Stage I to 11, or Stage I-Ill are significantly different between the two groups, the p value is noted. Two patients scheduled for the control group required bolus doses of nitroglycerin and so A were excluded from the trial. The first developed severe angina just before induction and so was given nitroglycerin 100 Ilg intravenously, with complete relief of pain. The second patient developed tachycardia and hypertension following intubation, together with raised ST segments in all ECG leads, finally becoming hypotensive with an increasing pulmonary diastolic pressure. Nitroglycerin 100 Ilg intravenously produced an immediate normalisation of the ECG and pressures. The course of events is depicted in Figures 5, 6 and 7.
DISCUSSION

During
anaesthesia and surgery, cardiovascular dynamics change frequently in response to changing levels of stimulation and anaesthesia. To isolate the effects of an additional drug -nitroglycerin -we elected to use a control group with which to compare haemodynamic changes produced by that drug. No comparisons were made within each group between the different stages.
We found that nitroglycerin lowered both systemic and pulmonary systolic pressure, vascular resistances and filling pressures. Systemic and venous oxygen saturations were kept lower, and the PaC02 did not fall as much. The mean endocardial viability ratio was higher in the nitroglycerin group.
Other workers have already demonstrated that nitroglycerin controls the hypertension due to surgical stress. Its intraoperative use was first described by Viljoen 4 , 5 in papers detailing his approach to anaesthesia for myocardial revascularisation. Kaplan et al. 6 reported on the haemodynamic changes during surgery, and described the effects of a nitroglycerin infusion. This was started when the systemic systolic pressure increased by more than 201110 or the mean arterial pressure exceeded 100 mmHg, and they found that 1 J.lg/kg/min was needed to return pressures to within 20% of baseline levels. Stengert et al. 7 administered bolus doses of nitroglycerin to patients with surgical hypertension, requiring 64-96 J.lg/min to return pressures to baseline levels. In a study comparing nitroglycerin with nitroprusside, Kaplan and Jones 8 used 0.9 J.lg/kg/min nitroglycerin but in a trial investigating nitroglycerin as a hypotensive agent during hip replacement, Fahmy9 administered 320 J.lg/min, decreasing systolic pressures to about 75 mmHg. Stetson lO found that 64-128 J.lg/min nitroglycerin together with deeper anaesthesia was necessary to control surgical hypertension.
In our study, nitroglycerin 3 J.lg/kg/min dropped the systemic systolic pressure by 20%, with little change in the control group at Stage Ill. No patient in the nitroglycerin group became markedly hypotensive and in four patients the systemic systolic pressure was higher than preinduction levels. In the control group, six patients became hypertensive after incision, though mean systemic systolic pressure was similar at all stages, reflecting the relatively stable conditions produced by high dose fentanyl anaesthesia.
The lower mean systemic systolic pressure in the nitroglycerin group at Stage III was due to a decrease in mean systemic vascular resistance, not to any change in the cardiac output which remained stable throughout the investigation period. In their series, Kaplan et al. 6 also demonstrated that nitroglycerin reduced systemic systolic pressure by decreasing systemic vascular resistance without affecting cardiac output. In patients following myocardial infarction, there may, in fact, be an increase in cardiac output with a nitroglycerin infusion ll if cardiac failure already exists, although other workers l2 found no change under these conditions. In a further trial, Bussman et al. 13 demonstrated that nitroglycerin increased cardiac output only in patients with left ventricular failure. In a study on patients undergoing coronary artery surgery, Franke et al. 14 found that in patients with poor preoperative left ventricular function, cardiac output decreased following surgical hypertension, and that this was returned to normal with a nitroglycerin infusion. Patients with normal left ventricular function showed no change in cardiac output following either surgical hypertension or nitroglycerin.
In our nitroglycerin group, mean systemic diastolic pressure did not differ from the control group, even though the mean systemic systolic pressure was lower. Thus nitroglycerin selectively lowered systolic pressure, and consequently cardiac work, without reducing diastolic pressure, the main contributor to coronary flow. Hempelman et al. 15 and Fahmy9 and Kaplan and J ones 8 also showed that nitroglycerin did not lower systemic diastolic pressure to the same extent as systolic pressure. It may be that the beneficial effect of this drug in cardiac ischaemia is partly due to its ability to decrease cardiac work without compromising myocardial oxygen supply.
Tachycardia was not observed in our patients, as all were receiving (3-blocking drugs. However, in his series of patients who were presumably not so treated, Fahmy9 reported significant increases in heart rate, 15 minutes after starting a nitroglycerin infusion.
However, Chestnut et al. 16 reported a stable heart rate in a group of neurosurgical patients receiving a nitroglycerin infusion. In their comparison of nitroglycerin and nitroprusside in (3-blocked surgical patients, Kaplan and Jones 8 reported a tachycardia only with the highest doses of both drugs (nitroglycerin 96 J.lg/min, nitroprusside 60 J.lg/min) and Stengert et al. 7 found no increase in heart rate in (3-blocked patients given bolus doses (96 J.lg) of ni trogl ycerin.
We found no change in the rate pressure product, even though the mean systemic systolic pressure was lower in the nitroglycerin group at Stage Ill, because there was a slight, though insignificant rise in heart rate at the same time. This finding is at variance with other series 6 ,15 which have shown a significant decrease in rate pressure product after nitroglycerin. However, these workers made their measurements at least 15 minutes after sternotomy, when the main surgical stimulus was over, while our Stage III measurements were made immediately after sternotomy. It would appear from our results that it is difficult to improve on high dose fentanyl anaesthesia with regard to this index of myocardial oxygen demand.
Pulmonary artery pressures were similar in both groups before surgery, and nitroglycerin prevented the rise seen in the control group after sternotomy. The pulmonary wedge pressure also remained normal with nitroglycerin, reflecting a lower left ventricular filling pressure, which was not associated with a significantly lower cardiac or stroke index.
In the control group, the higher post sternotomy systemic systolic pressures and pulmonary wedge pressures resulted in a decrease in the mean endocardial viability ratio, an index of subendocardial oxygen supply over demand. 2 ,3 Nitroglycerin maintained the mean endocardial viability ratio at pre-induction levels by keeping pulmonary wedge pressure and systemic systolic pressure low without changing systemic diastolic pressures.
In both groups, there was a significant increase in arterial oxygen saturations following induction, but by Stage Ill, there was a significantly smaller increase in saturation in the nitroglycerin group, together with a significant increase in the PaC02' It has already been demonstrated that sublingual nitroglycerin produces a fall in the arterial oxygen saturation in conscious patients breathing air 17 ,18 and these workers have postulated a ventilation perfusion mismatch due to a nitroglycerin induced block of the pulmonary hypoxic vasoconstrictor reflex. The rise in P aco2 may have been due to the bronchial dilation said to be produced by nitroglycerin. 19 Kopman et al. 17 found no change in Paco2 in their conscious subjects, possibly due to a reflex rise in alveolar Anaesthesia and Intensive Care, Vol. IX, No. 3, August, 1981 ventilation. Our anaesthetised patients could not so respond.
Apart from the two patients mentioned earlier, and excluded from the series, we found no difference in ECG changes between the two groups, although in some patients in both groups there were minor transient changes in ST segments. The patient whose course is depicted in Figures 5, 6 and 7 , appeared to be about to have a circulatory arrest with a declining blood pressure, rising pulmonary pressures and raised ST segments. It is interesting to note the paradoxical rise in systemic pressures following the bolus dose of nitroglycerin, presumably brought about by an improvement in factors influencing myocardial con tractility .
We have demonstrated that in patients anaesthetised for coronary artery surgery, a nitroglycerin infusion favourably affects pulmonary and systemic pressures and the indices of sub-endocardial flow, without decreasing cardiac efficiency. In acute myocardial ischaemic episodes during anaesthesia, bolus doses of nitroglycerin may be life-saving.
